** Shares of medical equipment maker Illumina rise 1.8% to $146.9

** Illumina reports preliminary Q4 revenue of around $1.1 bln, above analysts' estimates of $1.07 bln, according to data compiled by LSEG

** Company expects Q4 non-GAAP diluted EPS in the range of $0.91 to $0.93, vs estimates of $0.91 - LSEG

** ILMN forecasts non-GAAP diluted EPS in the range of $4.12 to $4.14 for fiscal 2024, compared to its earlier forecast of $4.05 to $4.15

** For FY25, company expects revenue to be between $4.28 bln and $4.4 bln, compared to analysts' estimates of $4.48 bln; also expects non-GAAP diluted EPS growth of around 10% compared to the same period a year ago

** Company expects to report full Q4 results on Feb. 6 after markets close

** ILMN stocks fell 1.25% in 2024

(Reporting by Sanchayaita Roy in Bengaluru)

((sanchayaita.roy@thosmonreuters.com))